GCM
Graham Capital Management’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $458K | Buy |
+4,384
| New | +$458K | 0.01% | 823 |
|
|
2024
Q2 | – | Sell |
-9,553
| Closed | -$762K | – | 1017 |
|
|
2024
Q1 | $762K | Buy |
+9,553
| New | +$762K | 0.01% | 474 |
|
|
2023
Q4 | – | Sell |
-13,255
| Closed | -$926K | – | 979 |
|
|
2023
Q3 | $926K | Buy |
+13,255
| New | +$926K | 0.02% | 375 |
|
|
2022
Q2 | – | Sell |
-101,851
| Closed | -$4.22M | – | 995 |
|
|
2022
Q1 | $4.22M | Buy |
101,851
+78,518
| +337% | +$3.25M | 0.15% | 62 |
|
|
2021
Q4 | $881K | Buy |
+23,333
| New | +$881K | 0.04% | 99 |
|